Published in MedGenMed on July 05, 2007
Multidrug resistant acinetobacter. J Glob Infect Dis (2010) 1.94
Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis (2010) 1.17
Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis. BMC Res Notes (2014) 1.01
A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain. Antimicrob Agents Chemother (2013) 0.94
Global transcriptome and physiological responses of Acinetobacter oleivorans DR1 exposed to distinct classes of antibiotics. PLoS One (2014) 0.81
Case fatality rate related to nosocomial and ventilator-associated pneumonia in an ICU: a single-centre retrospective cohort study. Wien Klin Wochenschr (2015) 0.79
Current advances and challenges in the development of Acinetobacter vaccines. Hum Vaccin Immunother (2015) 0.78
Acinetobacter pneumonia: Is the outcome different from the pneumonias caused by other agents. Ann Thorac Med (2010) 0.78
Resilient microorganisms in dust samples of the International Space Station-survival of the adaptation specialists. Microbiome (2016) 0.75
Multiple lung abscesses due to acinetobacter infection: a case report. Cases J (2009) 0.75
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med (2005) 23.85
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev (1996) 13.25
Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev (2005) 12.07
Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis (2005) 9.06
Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med (1999) 7.90
Interspecies transformation of Acinetobacter: genetic evidence for a ubiquitous genus. J Bacteriol (1972) 7.49
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis (2006) 7.36
The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis (2006) 7.29
Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis (2005) 6.60
Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet (2006) 6.32
Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med (1999) 6.23
Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother (2006) 4.80
Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies. Medicine (Baltimore) (1977) 4.05
Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest (2002) 3.98
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis (2006) 3.93
Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol (2003) 3.74
Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis (2007) 3.73
Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect (2005) 3.70
Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes. J Antimicrob Chemother (2002) 3.46
Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis (2003) 3.37
Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol (1998) 3.02
Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis (2005) 2.98
The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis (2006) 2.94
Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol (1997) 2.91
Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb Mortal Wkly Rep (2004) 2.81
Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med (2002) 2.64
Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia. Clin Infect Dis (1992) 2.60
Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother (2005) 2.47
Severe community-acquired pneumonia due to Acinetobacter baumannii. Chest (2001) 2.46
An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J Hosp Infect (1990) 2.24
Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest (1999) 2.13
Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care (2006) 2.07
Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Ann Pharmacother (2004) 1.99
Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel. Antimicrob Agents Chemother (2006) 1.85
A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect (2004) 1.74
Treatment of multidrug resistant Acinetobacter. Curr Opin Infect Dis (2005) 1.72
Molecular characterization of bla(IMP-5), a new integron-borne metallo-beta-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. FEMS Microbiol Lett (2002) 1.69
Acinetobacter baumannii in human body louse. Emerg Infect Dis (2004) 1.58
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care (2005) 1.58
The skin as the source of Acinetobacter and Moraxella species occurring in blood cultures. J Clin Pathol (1979) 1.57
Acinetobacter skin colonization of US Army Soldiers. Infect Control Hosp Epidemiol (2006) 1.57
Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest (2006) 1.57
An outbreak of infections with Acinetobacter calcoaceticus in burn patients: contamination of patients' mattresses. J Infect Dis (1985) 1.56
Use of colistin in the treatment of multiple-drug-resistant gram-negative infections. Am J Health Syst Pharm (2005) 1.54
Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med (2005) 1.53
Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin Infect Dis (2006) 1.52
Fatal Acinetobacter baumannii infection with discordant carbapenem susceptibility. Clin Infect Dis (2005) 1.51
Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control Hosp Epidemiol (2004) 1.46
Pillows, an unexpected source of Acinetobacter. J Hosp Infect (1995) 1.43
Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases. J Hosp Infect (1999) 1.40
Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations. Antimicrob Agents Chemother (1997) 1.39
Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med (2000) 1.37
Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. J Hosp Infect (2002) 1.36
What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? Clin Infect Dis (2006) 1.34
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. J Antimicrob Chemother (2004) 1.33
Impact of Acinetobacter infection on the mortality of burn patients. J Am Coll Surg (2006) 1.33
Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J Infect (2006) 1.32
Infectious diseases during wartime. Curr Opin Infect Dis (2005) 1.31
Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq. Lancet Infect Dis (2006) 1.31
Computer keyboards as reservoirs for Acinetobacter baumannii in a burn hospital. Clin Infect Dis (1999) 1.30
Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med (1999) 1.26
Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Clin Microbiol Infect (2006) 1.22
Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients. J Clin Pharmacol (2006) 1.21
Optimizing antimicrobial pharmacodynamics: dosage strategies for meropenem. Clin Ther (2004) 1.18
Community-acquired Acinetobacter calcoaceticus var anitratus pneumonia. JAMA (1977) 1.15
Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. Clin Infect Dis (2002) 1.14
The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Clin Med Res (2006) 1.14
Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria. Eur J Clin Microbiol Infect Dis (2006) 1.13
Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis (2005) 1.13
Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect (1997) 1.12
Pathogenic significance of Acinetobacter calcoaceticus: analysis of experimental infection in mice. Microbiol Immunol (1986) 1.11
Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections. J Antimicrob Chemother (2006) 1.10
Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey. Intensive Care Med (2003) 1.10
Bacteraemia in cancer patients caused by colistin-resistant Gram-negative bacilli after previous exposure to ciprofloxacin and/or colistin. Clin Microbiol Infect (2006) 1.08
Metallo-beta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp. Diagn Microbiol Infect Dis (2004) 1.07
Gram-negative bacilli as nontransient flora on the hands of hospital personnel. J Clin Microbiol (1987) 1.06
Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia. Chest (1997) 1.06
Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia. Clin Infect Dis (2006) 1.01
Hand carriage of aerobic Gram-negative rods by health care personnel. J Hyg (Lond) (1982) 0.98
Acinetobacter: epidemiological and taxonomic aspects. APMIS Suppl (1994) 0.98
Community-acquired bacteraemic Acinetobacter pneumonia with survival. Postgrad Med J (1993) 0.93
Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp. Int J Antimicrob Agents (2005) 0.91
Fulminant community-acquired Acinetobacter pneumonia in a healthy woman. Clin Infect Dis (1993) 0.89
Polymyxin inhalation therapeutic hazard. Ann Intern Med (1971) 0.89
Community-acquired acinetobacter pneumonia. Am J Med (1979) 0.87
Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study. Surg Infect (Larchmt) (2007) 0.87
Acinetobacter nares colonization of healthy US soldiers. Infect Control Hosp Epidemiol (2006) 0.87
Nosocomial respiratory tract colonization and infection with aminoglycoside-resistant Acinetobacter calcoaceticus var anitratus: epidemiologic characteristics and clinical significance. Infect Control Hosp Epidemiol (1988) 0.86
An outbreak of nosocomial Acinetobacter infections from humidifiers. Am J Infect Control (1985) 0.85
Community-acquired Acinetobacter pneumonia: a case report. J Infect (1997) 0.84
Epidemic Acinetobacter baumannii strain with MRSA-like behaviour carried by healthcare staff. Eur J Clin Microbiol Infect Dis (2002) 0.84
Community-acquired Acinetobacter pneumonia. Aust N Z J Med (1989) 0.83
Community acquired Acinetobacter pneumonia: report of two cases. Southeast Asian J Trop Med Public Health (1989) 0.82
Community-acquired Acinetobacter pneumonia in Thailand. Report of 5 cases. J Med Assoc Thai (1987) 0.82
[CLINICAL OBSERVATIONS ON THE ACTIVITY OF AEROSOL COLIMYCIN AND OF ENDOBRONCHIAL INSTILLATIONS OF COLIMYCIN IN PATIENTS WITH PULMONARY SUPPURATIONS]. Minerva Med (1963) 0.81
Treatment of pan-drug resistant Acinetobacter baumannii. Scand J Infect Dis (2005) 0.78
A case of Acinetobacter calcoaceticus pneumonia. Thorax (1995) 0.76
Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis (2005) 2.98
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. PLoS One (2009) 2.49
Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement. Biosecur Bioterror (2006) 2.43
Ehrlichiosis: making the diagnosis in the acute setting. South Med J (2007) 2.22
Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigen. J Clin Microbiol (2003) 2.08
In harm's way: infections in deployed American military forces. Clin Infect Dis (2006) 2.00
Community meetings for emergency research community consultation. Crit Care Med (2008) 1.58
Invasive mold infections following combat-related injuries. Clin Infect Dis (2012) 1.55
Innovative surveillance methods for rapid detection of disease outbreaks and bioterrorism: results of an interagency workshop on health indicator surveillance. Am J Public Health (2003) 1.46
The remote diagnosis of malaria using telemedicine or e-mailed images. Mil Med (2006) 1.44
Infectious diseases during wartime. Curr Opin Infect Dis (2005) 1.31
Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. PLoS One (2011) 1.14
De novo daptomycin nonsusceptibility in a clinical isolate. J Clin Microbiol (2006) 1.08
Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers. Biosecur Bioterror (2004) 1.02
Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release. J Neurochem (2006) 1.00
Vesicular reuptake inhibition by a synaptotagmin I C2B domain antibody at the squid giant synapse. Proc Natl Acad Sci U S A (2004) 0.96
Enzymatically incorporated genomic tags for optical mapping of DNA-binding proteins. Angew Chem Int Ed Engl (2012) 0.95
Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009. Emerg Infect Dis (2015) 0.93
Atypical Q fever in US soldiers. Emerg Infect Dis (2007) 0.92
Multiple fractures of the symphysis pubis due to tuberculous osteomyelitis. Southeast Asian J Trop Med Public Health (2009) 0.88
Experience in the medical management of potential laboratory exposures to agents of bioterrorism on the basis of risk assessment at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). J Occup Environ Med (2004) 0.87
Niacin: the evidence, clinical use, and future directions. Curr Atheroscler Rep (2012) 0.83
Toward single-molecule optical mapping of the epigenome. ACS Nano (2013) 0.81
Seroprevalence and seroincidence of herpes simplex virus (2006-2010), syphilis (2006-2010), and vaccine-preventable human papillomavirus subtypes (2000-2010) among US military personnel. Sex Transm Dis (2015) 0.80
Caring for patients with Ebola: a challenge in any care facility. Ann Intern Med (2014) 0.79
Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms. Ann Clin Microbiol Antimicrob (2007) 0.79
Management guidelines for laboratory exposures to agents of bioterrorism. J Occup Environ Med (2004) 0.79
Differential calcium dependence of axonal versus somatodendritic dopamine release, with characteristics of both in the ventral tegmental area. Front Syst Neurosci (2011) 0.79
Compliance with pharmacotherapy and direct healthcare costs in patients with Parkinson's disease: a retrospective claims database analysis. Appl Health Econ Health Policy (2013) 0.78
Medical management of the suspected victim of bioterrorism: an algorithmic approach to the undifferentiated patient. Emerg Med Clin North Am (2002) 0.78
Human papillomavirus seroprevalence among men entering military service and seroincidence after ten years of service. MSMR (2013) 0.78
Military medical education: nuclear, biological, and chemical medical defense training as a model for planners. Mil Med (2004) 0.78
A soldier with traumatic brain injury and meningitis. Clin Infect Dis (2005) 0.77
Sulfur mustard: a liquid, not a gas. Clin Infect Dis (2011) 0.75
Fulminant supraglottitis from Neisseria meningitidis. Emerg Infect Dis (2007) 0.75
Reaction after smallpox vaccination. Am Fam Physician (2006) 0.75
Plasmacytoma-like Posttransplant Lymphoproliferative Disorder in a Pediatric Heart Transplant Recipient. J Pediatr Hematol Oncol (2016) 0.75
Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates. Emerg Infect Dis (2017) 0.75